Cetera Advisors’s Geron GERN Stock Holding History

Cetera Advisors’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,230	Closed	-$17K	–	1473
2021 Q3	$17K	Buy	+12,230	New	+$16.3K	﹤0.01%	1397

Other funds holding GERN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cetera Advisors's GERN Position: Q4 2021 in Review

Cetera Advisors sold out of Geron (GERN) in Q4 2021, closing a stake of 12,230 shares — an estimated $17K sold.

Cetera Advisors first reported a position in GERN in Q3 2021 and held it in 1 quarter. The position peaked at $17K in Q3 2021. 147 funds tracked by Wall St. Rank hold GERN as of Q4 2021.

Cetera Advisors reported no remaining Geron position as of Q4 2021 after selling out during the quarter.
Cetera Advisors sold 12,230 Geron shares in Q4 2021, an estimated $17K.
Cetera Advisors first reported a position in Geron in Q3 2021 and held it in 1 quarter.
Cetera Advisors's Geron position peaked at $17K in Q3 2021.
147 funds tracked by Wall St. Rank held Geron as of Q4 2021.

Based on Cetera Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.